An overview of the bioactivity of monacolin K / lovastatin.
Bioactivity
Lovastatin
Monacolin K
Monascus
Red yeast rice
Statins
Journal
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
30
01
2019
revised:
01
06
2019
accepted:
13
06
2019
pubmed:
18
6
2019
medline:
10
9
2019
entrez:
18
6
2019
Statut:
ppublish
Résumé
Monacolin K (MK) is the principal active substance in Monascus-fermentation products (e.g. red yeast rice). MK is effective in reducing cholesterol levels in humans and has been widely used as a lipid-lowering drug. The mechanism for this is through a high degree of competitive inhibition of the rate-limiting enzyme HMG-CoA reductase (HMGR) in the cholesterol synthesis pathway. In addition to lowering blood lipid levels, MK also prevents colon cancer, acute myeloid leukemia and neurological disorders such as Parkinson's disease and type I neurofibromatosis. The aim of this manuscript is to comprehensively review the progress in the study of the biological activity of MK and its imechanism of action in reducing blood lipid concentration, prevention of cancer and its neuroprotective, anti-inflammatory and antibacterial properties. This review provides a reference for future applications of MK in functional foods and medicine.
Identifiants
pubmed: 31207306
pii: S0278-6915(19)30374-6
doi: 10.1016/j.fct.2019.110585
pii:
doi:
Substances chimiques
Biological Products
0
red yeast rice
0
Lovastatin
9LHU78OQFD
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
110585Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.